Patients should seek emergency care if they experience persistent right upper quadrant pain lasting more than 6 hours, fever above 100.4F (38C), jaundice, severe vomiting preventing oral intake, or signs of sepsis such as confusion or rapid heart rate
Start slowly with 'gentler fiber,' like oatmeal, bananas, zucchini, and cooked vegetables, Susie says
No claims are made regarding therapeutic applications, clinical efficacy, physiological outcomes, or suitability for human or veterinary use
What we know: Retatrutide activates GLP-1, GIP, and glucagon receptors simultaneously Phase 2/3 trials show 24-29% weight loss at highest doses Side effects are similar to other incretin medications (mainly GI) It may be particularly effective for liver fat reduction FDA approval is potentially years away What to consider: Approved alternatives (semaglutide, tirzepatide) have established safety profiles "GLP-3" marketing may oversimplify or mislead Investigational drugs carry unknown long-term risks Quality control for compounded versions is variable Clinical trial results don't always translate to real-world outcomes The bigger picture: Retatrutide may represent a genuine advance in obesity treatmentthe data is genuinely impressive
Sivakumar, P
The number of people served by the compounded drug is extraordinary